Invitae Appoints Ana Schrank as its new CFO
Invitae (NYSE: NVTA), a prominent medical genetics company, has announced the appointment of finance veteran Ana Schrank as its new Chief Financial Officer, effective from October 2. Robert Dickey, who has served as the Company's interim CFO since August 2023, will transition to a consulting role within the Company and...